Breast Cancer Organoids Model Patient-Specific Response to Drug Treatment
Tumor organoids are tridimensional cell culture systems that are generated in vitro from surgically resected patients’ tumors. They can be propagated in culture maintaining several features of the tumor of origin, including cellular and genetic heterogeneity, thus representing a promising tool for p...
Main Authors: | Elena Campaner, Alessandro Zannini, Mariangela Santorsola, Deborah Bonazza, Cristina Bottin, Valeria Cancila, Claudio Tripodo, Marina Bortul, Fabrizio Zanconati, Stefan Schoeftner, Giannino Del Sal |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/12/3869 |
Similar Items
-
Organoids and Colorectal Cancer
by: Antonio Barbáchano, et al.
Published: (2021-05-01) -
BMP‐2 Signaling and Mechanotransduction Synergize to Drive Osteogenic Differentiation via YAP/TAZ
by: Qiang Wei, et al.
Published: (2020-08-01) -
Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank
by: Zilong Zhou, et al.
Published: (2021-12-01) -
Data on the evaluation of the relation between β-arrestin 2 and YAP phosphorylation in patient-derived colon cancer organoids
by: Minsuh Kim, et al.
Published: (2022-10-01) -
Multifocal Organoid Capturing of Colon Cancer Reveals Pervasive Intratumoral Heterogenous Drug Responses
by: Soon‐Chan Kim, et al.
Published: (2022-02-01)